- ►annals.org [PDF] TD Shanafelt, JC Byrd, TG Call, CS Zent, NE … - Annals of internal medicine, 2006 - Am Coll Physicians Chronic lymphocytic leukemia is one of the most common malig- nant lymphoid
diseases in the western world and is frequently diagnosed by internists. There
have been clinically significant changes in method of diagnosis, prognostic ... Cited by 25 - Related articles - All 3 versions
C Schollkopf, D Rosendahl, K Rostgaard, C … - International Journal of Cancer, 2007 - interscience.wiley.com Smoking is not considered a risk factor for chronic lymphocytic leukemia (CLL)
yet increased lung cancer risk has been reported for these patients. Little data
exist on the temporal variation in lung cancer risk after CLL, or its ... Cited by 9 - Related articles - BL Direct - All 5 versions
[CITATION] Chronic lymphocytic leukemia in early stage" smoldering" and" active" forms in chronic …
TS Lin, B Fischer, ME Moran, RS Shank, E … - Journal of Clinical Oncology, 2006 - Am Soc Clin Oncol Background: The cyclin-dependent kinase inhibitor flavopiridol is active in MCL
and chronic lymphocytic leukemia (CLL) when given by 1-hr IV bolus dosing.
Flavopiridol induces apoptosis independent of p53 and may eliminate tumor ... Cited by 7 - Related articles - All 2 versions
- ►hematologylibrary.org WG Wierda - Hematology, 2006 - asheducationbook.hematologylibrary.org Clinical and laboratory investigations are driving the rapid change in
treatments for patients with chronic lymphocytic leukemia (CLL). Randomized
trials have demonstrated superior activity for fludarabine combined with ... Cited by 15 - Related articles - All 4 versions
K Maddocks-Christianson, SL Slager, CS Zent … - British journal of haematology, 2007 - interscience.wiley.com Previous studies suggested that patients with chronic lymphocytic leukaemia
(CLL) are at a three- to fivefold increased risk of developing a second
lymphoproliferative disorder (LPD). This observational cohort study used ... Cited by 16 - Related articles - BL Direct - All 4 versions
AM Tsimberidou, S O'Brien, HM Kantarjian, C … - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 16 - Related articles - BL Direct - All 4 versions
TJ Hamblin, ZA Davis, DG Oscier - British Journal of Haematology, 2008 - interscience.wiley.com The choice of 98% sequence homology for immunoglobulin heavy chains to
distinguish between mutated and unmutated versions of chronic lymphocytic
leukaemia (CLL) was arbitrary and was chosen to account for supposed ... Cited by 6 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org KA Blum, D Young, S Broering, MS Lucas, B … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Purpose National Cancer Institute–sponsored Working Group (NCI-WG) response
criteria for chronic lymphocytic leukemia (CLL) rely on physical examination,
blood, and bone marrow evaluations. The widespread use of computed ... Cited by 6 - Related articles - All 4 versions
- ►ascopubs.org A Muntanola, F Bosch, P Arguis, E Arellano- … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Purpose Whether computed tomography (CT) should be routinely included in the
diagnostic work-up in patients with chronic lymphocytic leukemia (CLL) has not
yet been determined. The aim of this study was to analyze the prognostic ... Cited by 17 - Related articles - All 6 versions
